SCHEMBL18090071

SCHEMBL18090071

c1ccc([Si](c2ccccc2)(c2cccc3c2oc2ccc(-n4c5ccccc5c5ccccc54)cc23)c2cccc3c2oc2ccc(-n4c5ccccc5c5ccncc54)cc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 3/20 0.34
CDK6 Q00534 3/20 0.34
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18089898 1.00 CDK4 (0.34) CDK4CDK6KDM4EATML3MBTL1
SCHEMBL18090069 0.94 MAOA (0.35) CDK4CDK6KDM4EATML3MBTL1
SCHEMBL18089885 0.91 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL18090032 0.90
SCHEMBL18090015 0.90
SCHEMBL18089975 0.90
SCHEMBL16118447 0.89 KDM4E (0.38) KDM4EATML3MBTL1
SCHEMBL18089919 0.88 MAOA (0.31)
SCHEMBL26304959 0.87 KDM4E (0.36) KDM4EATML3MBTL1
SCHEMBL18089927 0.87 CDK4 (0.35) CDK4CDK6KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780316-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-03 US disclosed
US-9780316-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-03 US disclosed
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-22 US disclosed
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES RB1, LEF1, BRD1 CDK4 1284/4885CDK6 2818/4885KDM4E 2321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.